Finance

Lists
BVS:NASDAQ
Bioventus Inc
US$ १३.९७
-१.१०%
(-०.१५) 1D
अगस्ट १०, १०:४५:०६ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BVS...
Open
US$ १३.८९
High
US$ १३.९८
Low
US$ १३.४४
Mkt. cap
१.१९ अरब
Avg. vol.
८.५१ लाख
Volume
१.३८ लाख
52-wk high
US$ १५.८९
52-wk low
US$ ६.२६
Beta
०.६३
Shares outstanding
६.८३ करोड
No. of employees
९५०
Open
US$ १३.८९
High
US$ १३.९८
Low
US$ १३.४४
Mkt. cap
१.१९ अरब
Avg. vol.
८.५१ लाख
Volume
१.३८ लाख
52-wk high
US$ १५.८९
52-wk low
US$ ६.२६
Beta
०.६३
Shares outstanding
६.८३ करोड
No. of employees
९५०
News stories
From sources across the web
About Bioventus Inc
CEO-
Employees९५०
Founded२०११
Headquarters-
Sector-
Websitebioventus.com
Analyst ratings
Based on 3 analysts giving stock ratings to BVS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for BVS in the last 3 months.
Highest
Current US$ १३.९७
US$ १८.०० (+२८.८५%)
Average
US$ १७.०० (+२१.६९%)
Lowest
US$ १५.०० (+७.३७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
US$ १५.००
+७.४%
08/05/2026
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
US$ १८.००
+२८.८%
08/06/2026
Michael Petusky
Barrington
Buy
Maintained
US$ १८.००
+२८.८%
08/06/2026
Lawrence Solow
CJS Securities
Buy
Initiated
US$ १४.००
+०.२%
03/27/2026
Last report
२०२६ अगस्ट ५
Fiscal period
Q2 2026
EPS / Est. (USD)
US$ ०.२२ / US$ ०.२२
+०.९२%beat
Revenue / Est. (USD)
१५.३२ करोड / १५.५६ करोड
-१.५६%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१३.८७ करोड
१५.७९ करोड
१३.२१ करोड
१५.३२ करोड
Cost of goods sold
४.४४ करोड
४.९१ करोड
४.१३ करोड
४.७५ करोड
Cost of revenue
४.४४ करोड
४.९१ करोड
४.१३ करोड
४.७५ करोड
Research and development expenses
२९.२३ लाख
३०.०७ लाख
२४.६७ लाख
३१.७३ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७.८६ करोड
८.२८ करोड
७.८३ करोड
८.२७ करोड
Operating expense
८.३० करोड
८.७१ करोड
८.१९ करोड
८.६९ करोड
Total operating expenses
१२.७४ करोड
१३.६२ करोड
१२.३२ करोड
१३.४५ करोड
Operating income
१.१३ करोड
२.१७ करोड
८८.८९ लाख
१.८७ करोड
Other non operating income
-७९.०० हजार
-२०.१३ लाख
४.२७ लाख
-
EBT including unusual items
४६.७० लाख
१.४१ करोड
४५.१७ लाख
१.५३ करोड
EBT excluding unusual items
५०.०९ लाख
१.६४ करोड
४९.९० लाख
१.४९ करोड
Income tax expense
६.६४ लाख
-३१.७५ लाख
५.७१ लाख
-२.०९ करोड
Effective tax rate
१४.२२%
-२२.४५%
१२.६४%
-१३६.५१%
Other operating expenses
-
-
-
-
Net income
३१.५५ लाख
१.४८ करोड
३१.१३ लाख
३.३४ करोड
Net profit margin
२.२८%
९.३४%
२.३६%
२१.८३%
Earnings per share
०.१५
०.२४
०.१५
०.२२
Interest and investment income
-
-
-
-
Interest expense
-६१.७७ लाख
-५३.०६ लाख
-४३.२६ लाख
-४०.६८ लाख
Net interest expenses
-६१.७७ लाख
-५३.०६ लाख
-४३.२६ लाख
-४०.६८ लाख
Depreciation and amortization charges
१३.९८ लाख
१२.९७ लाख
११.०७ लाख
१०.४१ लाख
EBITDA
२.२७ करोड
२.७० करोड
२.०१ करोड
२.९७ करोड
Gain or loss from assets sale
-१.०० हजार
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू